NCT03196180View on ClinicalTrials.gov

Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

October 15, 2019

Primary Completion Date

November 4, 2020

Study Completion Date

August 2, 2024

Conditions
Cervical Intraepithelial Neoplasia Grade 2/3Cervical Squamous Cell Carcinoma In SituCervical Squamous Intraepithelial Neoplasia 2High Grade Cervical Intraepithelial Neoplasia
Interventions
DRUG

Imiquimod

Given intravaginally

DRUG

Topical Fluorouracil

Given intravaginally

Trial Locations (1)

27599

UNC Lineberger Comprehensive Cancer Center, Chapel Hill

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT03196180 - Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia | Biotech Hunter | Biotech Hunter